Is bezafibrate histologically effective for primary biliary cirrhosis? [17]

American Journal of Gastroenterology

Volumn 97, Issue 4, 2002, Pages 1075-1077

  Yano, Koji ^a,b   Kato, Hiroyuki ^a   Morita, Shigeki ^a   Takahara, Osamu ^a   Ishibashi, Hiromi ^b   Furukawa, Ryuji ^a  

^a JAPANESE RED CROSS NAGASAKI GENBAKU HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; MITOCHONDRION ANTIBODY; URSODEOXYCHOLIC ACID;

ADULT; AGED; CASE REPORT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; LETTER; LIVER BIOPSY; LIVER FUNCTION TEST; MALE; NEEDLE BIOPSY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036117828     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04001-7     Document Type: Letter

References (10)

1. Primary biliary cirrhosis
2. Ursodiol for the long-term treatment of primary biliary cirrhosis
3. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
4. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression
5. Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: A preliminary study
6. Bezafibrate in the treatment of primary biliary cirrhosis: Comparison with ursodeoxycholic acid
7. A novel treatment for refractory primary biliary cirrhosis?
8. Long-term administration of bezafibrate on primary biliary cirrhosis
9. The effect of bezafibrate treatment on serum alkaline phosphatase isoenzyme activities
10. Natural history of early primary biliary cirrhosis